Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 421 - 440 of 486 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of Intratumoral Clostridium novyi-NT Spores in Patients with Persistent Solid Tumors
[Protocol 14-087]
Gounder, Mrinal
  • Solid Tumors
A Phase I Study of Intrathecal Radioimmunotherapy Using 131I-8H9 for Central Nervous System/Leptomeningeal Cancers
[Protocol 03-133]
Kramer, Kim
  • Brain Tumors, Primary
  • Neuroblastoma
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Phase I Study of Intraperitoneal Radioimmunotherapy with 131I-8H9 for Patients with Desmoplastic Small Round Cell Tumors and Other Solid Peritoneal Tumors
[Protocol 09-090]
Modak, Shakeel
A Phase I Study of INK128 (MLN0128) in Patients with Advanced Kidney, Bladder, or Endometrial Cancer
[Protocol 13-118]
Voss, Martin
  • Bladder Cancer
  • Kidney Cancer
A Phase I Study of Induction Chemotherapy with Afatinib, Ribavirin, and Carboplatin/Paclitaxel in Patients with Stage IV HPV-Associated Oropharynx Cancer
[Protocol 12-150]
Fury, Matthew
  • Head & Neck Cancer
A Phase I Study of IMGN529 in Patients with Recurrent or Persistent Non-Hodgkin Lymphoma
[Protocol 13-073]
Palomba, M. Lia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of Hypofractionated Stereotactic Radiosurgery with Bevacizumab to Treat Recurrent Malignant Glioma
[Protocol 11-057]
Omuro, Antonio
  • Brain Tumors, Primary
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
Relapsed/Refractory
[Protocol 12-116]
Roberts, Stephen
  • Neuroblastoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
A Phase I Study of Humanized 3F8 Monoclonal Antibody in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 11-009]
Basu, Ellen
  • Neuroblastoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
A Phase I Study of High-Dose-Rate Brachytherapy plus Chemotherapy in Patients with Recurrent Rectal or Anal Cancer
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-104]
Goodman, Karyn
  • Colorectal Cancer
    • Rectal Cancer
A Phase I Study of High-Dose Therapy and Autologous Stem Cell Transplantation Followed by Modified T Cells for Aggressive B-Cell Non-Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 12-117]
Sauter, Craig
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of HER2/neu DNA Immunization for Patients with Metastatic or High-Risk Breast Cancer
[Protocol 04-101]
Gilewski, Teresa
  • Breast Cancer
A Phase I Study of Hepatic Arterial Infusion with Floxuridine, Dexamethasone, and Gemcitabine after Surgery for Liver Cholangiocarcinoma
[Protocol 13-148]
Cercek, Andrea
  • Hepatobiliary
    • Liver Cancer
A Phase I Study of HDM201 in Patients with Advanced Cancers and a Normal TP53 Gene
[Protocol 14-139]
Hyman, David
  • Colorectal Cancer
  • Germ Cell Tumors
  • Hematology
    • Hematologic Malignancies
    • Myelodysplastic Syndrome
  • Kidney Cancer
  • Leukemia
  • Melanoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
  • Solid Tumors
A Phase I Study of GL-ONC1 for Treating Malignant Pleural Effusion
[Protocol 12-169]
Rusch, Valerie
  • Breast Cancer
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
  • Lung Cancer, Small Cell
  • Mesothelioma
A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia
[Protocol 06-138]
Park, Jae
  • Leukemia
    • Chronic Lymphocytic Leukemia
A Phase I Study of Genetically Modified T Cells Targeting CD19 in Pediatric and Young Adult Patients with Relapsed B-Cell Acute Lymphoblastic Leukemia
Relapsed/Refractory
[Protocol 13-052]
Curran, Kevin
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Study of Ganetespib with Paclitaxel and Trastuzumab in Women with Metastatic Breast Cancer
[Protocol 13-168]
Modi, Shanu
  • Breast Cancer
A Phase I Study of EPZ-5676 to Treat Children with Recurrent or Persistent MLL-Mutant Acute Leukemia
Relapsed/Refractory
[Protocol 14-080]
Shukla, Neerav
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I Study of EPZ-5676 in Patients with Relapsed/Refractory Leukemia and Other Advanced Hematologic Cancers
[Protocol 12-181]
Tallman, Martin
  • Hematology
    • Hematologic Malignancies
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
    • Myeloproliferative Neoplasm